Bevacizumab modulates the process of fibrosisin vitro
Author:
Affiliation:
1. Qingdao Eye Hospital; Shandong Eye Institute; Shandong Academy of Medical Sciences; Qingdao China
Funder
Qingdao Municipal Science and Technology Bureau
Publisher
Wiley
Subject
Ophthalmology
Reference40 articles.
1. Retinopathy of prematurity: current concepts in molecular pathogenesis;Heidary;Semin Ophthalmol,2009
2. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders;Aiello;N Engl J Med,1994
3. Alternative treatments to inhibit VEGF in age-related choroidal neovascularisation: 2-year findings of the IVAN randomised controlled trial;Chakravarthy;Lancet,2013
4. Intraocular concentrations of growth factors and cytokines in retinal vein occlusion and the effect of therapy with bevacizumab;Funk;Invest Ophthalmol Vis Sci,2009
5. Short-term safety and efficacy of intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration;Rich;Retina,2006
Cited by 28 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Human Antigen R -mediated modulation of Transforming Growth Factor Beta 1 expression in retinal pathological milieu;Biochemistry and Biophysics Reports;2024-09
2. Inhibition of Connective Tissue Growth Factor Expression in Adult Retinal Pigment Epithelial-19 Cells by Blocking Yes-Associated Protein/Transcriptional Coactivator with PDZ-Binding Motif Activity;Journal of Ocular Pharmacology and Therapeutics;2024-05-01
3. Vascular Growth Factor Inhibition with Bevacizumab Improves Cardiac Electrical Alterations and Fibrosis in Experimental Acute Chagas Disease;Biology;2023-11-10
4. Fibroblasts mediate endothelium response to angiogenic cues in a newly developed 3D stroma engineered model;Biomaterials Advances;2023-11
5. Effect of a novel tyrosine kinase inhibitor nintedanib on bFGF and VEGF concentrations in a rabbit retinal vein occlusion model;International Journal of Ophthalmology;2023-09-18
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3